Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atazanavir pharmacokinetics in treatment-naive adults with HIV-1 receiving atazanavir/ritonavir plus emtricitabine/tenofovir
2007-003203-12Phase 2Completed
- Sponsor
- ANRS
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atazanavir, ritonavir and emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by ANRS. Primary endpoint: Primary pharmacokinetic parameters of atazanavir. Started Jun 2007; status: completed.
02
Drugs
atazanavirritonaviremtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-003203-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003203-12.